Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market Size - By Product (Instrument, Kit), Technology (PCR, DNA Sequencing, Microarray, INAAT), Animal (Companion, Livestock), Application (Infectious, Genetic), End-user, Global Forecast (2023 – 2032)

  • Report ID: GMI6325
  • Published Date: Jul 2023
  • Report Format: PDF

Veterinary Molecular Diagnostics Market Size

Veterinary Molecular Diagnostics Market size was valued at USD 298 million in 2022 and is anticipated to reach USD 678.8 million by 2032 at CAGR of 8.6%. Some of the major factors including rising adoption of companion animals, high prevalence of zoonotic and foodborne diseases, technological advancements in veterinary molecular diagnostic technologies, and increasing adoption of pet insurance.

Veterinary Molecular Diagnostics Market

The veterinary molecular diagnostics refers to the use of molecular techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray, to diagnose infectious diseases, genetic disorders, and other conditions in animals. The industry includes the products used for the analysis of animal DNA, RNA, and proteins to identify specific nucleic acid sequences or mutations associated with disease or predisposition to disease. These diagnostic tests are performed in diagnostic laboratories, veterinary hospitals & clinics, research institutions, and other animal care facilities to aid in the accurate diagnosis, treatment, and prevention of diseases in animals.

COVID-19 Impact

The COVID-19 pandemic has had a mixed impact on the global veterinary molecular diagnostics market. During the pandemic, due to the imposition of stringent restrictions such as lockdowns, social distancing regulations, and prioritization of essential services, many of the veterinary hospitals and clinics faced temporary closures or reductions in operations. During such situations, severe veterinary cases were only allowed to visit the veterinary clinics. The supply chain was disrupted by the COVID-19 pandemic, affecting the availability and distribution of diagnostic reagents, consumables, and equipment. Restrictions on import and export, logistical challenges, and rising demand for certain products have resulted in delays in the delivery of diagnostic supplies. As COVID cases declined, the strict restrictions were eased, increasing the number of visits to veterinary clinics and hospitals.

Veterinary Molecular Diagnostics Market Driving Factors

The rapidly rising pet population, increasing adoption of pet insurance, increasing animal healthcare expenditure, and high prevalence of zoonotic diseases is increasing demand for animal diagnostic tests including molecular diagnostic tests. The pet adoption rate in developed countries like U.S. is high, for instance, according to the 2021–2022 National Pet Owners Survey by the American Pet Products Association, 70% of U.S. households owned at least one type of pet. According to this survey, almost 69 million US households have at least one dog, and 45.3 million US households have at least one cat, about 9.9 million US households have birds, and 3.5 million US households have horses.

The origins of the COVID-19 pandemic, was believed to be a zoonotic disease that was transmitted from animals to humans, highlighted the potential risks associated with zoonotic diseases. Zoonotic diseases pose a substantial threat to humans as they are transferred from animals to humans. The outbreaks of avian influenza, rabies, and certain strains of coronaviruses have increased the importance of early detection, monitoring, and prevention of such zoonotic diseases. Veterinary molecular techniques play a vital role in detecting and monitoring zoonotic pathogens in animals. Different molecular tests such as PCR and DNA sequencing are employed to identify pathogens responsible for zoonotic diseases in companion animals, livestock, and wildlife.

Veterinary Molecular Diagnostics Market Analysis

Veterinary Molecular Diagnostics Market, By Product, 2021 - 2032(USD Million)

Based on products, the veterinary molecular diagnostics market is segmented into kits & reagents and instruments. The kits & reagents segment held highest market share and was valued at USD 209 million in 2022. The adoption of kits & reagents is increasing all over the globe with the increasing demand of infectious disease diagnostic testing in companion and livestock animals. Also, there is a growing demand for ready-to-use diagnostic kits and reagents that offer convenience and ease of use for veterinarians. These kits eliminate the need for extensive laboratory infrastructure and specialized expertise, making them more accessible in various healthcare settings. Kits and reagents are user-friendly, which makes them a more convenient option for veterinarians and other healthcare professionals.

Based on technology, the global veterinary molecular diagnostics market is categorized into PCR, DNA sequencing, microarray, and INAAT kits. PCR segment is further sub-categorized into real-time PCR and other PCRs. In 2022, the PCR segment is expected to witness considerable growth at CAGR of 8.9% by 2032. It is because PCR technology has been proven to be the most reliable and fastest technique to diagnose the cause of diseases. PCR offers high sensitivity, specificity, and rapid results, making it a valuable tool for the detection and monitoring of various infectious diseases in animals.

Based on application, the veterinary molecular diagnostics market is segmented into infectious, genetic, and other applications. The infectious diseases segment is sub-segmented into bacterial, viral, parasitic, and other infectious diseases. The infectious disease segment is expected to reach USD 362.3 million by 2032. The rising prevalence of infectious diseases in animals is high, driving the demand for accurate and timely diagnostics to identify and treat such diseases. Due to the high emphasis on public health and animal health, there is a high demand for the early detection and control of zoonotic diseases.

Veterinary Molecular Diagnostics Market Share, By Animal Type (2022)

Based on animal type, the veterinary molecular diagnostics market is divided into companion and livestock animals. The companion animals’ segment is sub-divided into dogs, cats, horses, and other companion animals, whereas the livestock animals segment is sub-divided into cattle, swine, poultry, and other livestock animals. The companion animal segment held largest market share of 63.8% in 2022 attributed to factors such as rising adoption of companion animals like dogs and cats in the countries, rising focus on pet health, increasing adoption of pet insurance and animal healthcare expenditure. The growing humanization of pets is leading to increasing number of pet owners taking their pets to veterinarians for regular check-ups, vaccination or for identifying the health status of their pets in order to maintain the overall health.

Based on end-user, the veterinary molecular diagnostics market is classified into diagnostic laboratories, veterinary clinics, veterinary hospitals, and other end-users. Diagnostic laboratories segment is expected grow at CAGR of 8.6% by 2032. Veterinary diagnostic laboratories have specialized expertise, skilled personnel, and well-equipped facilities for performing molecular diagnostics. Such laboratories have well-developed infrastructure, including advanced laboratory devices which improves the handling of complex diagnostic procedures effectively and precisely. It offers a wide range of molecular tests for diagnosing various infectious diseases, genetic conditions, and immune-related disorders in animals.

U.S. Veterinary Molecular Diagnostics Market Size, 2020- 2032(USD Million)

North America veterinary molecular diagnostics market is expected to grow at CAGR of 8.1% by 2032. North America has well-developed veterinary healthcare infrastructure, including veterinary hospitals, clinics, and specialized veterinary centers. The presence of skilled veterinarians, advanced veterinary diagnostic equipment and techniques, and a wide range of treatments and veterinary services.

The U.S. is one of the countries which has the largest pet populations in the world, with a significant number of households owning pets. In U.S., dogs and cats are the most common pets, but there is also a considerable population of birds, fish, small mammals, and reptiles.

Veterinary Molecular Diagnostics Market Share

The prominent players in the veterinary molecular diagnostics market are

  • IDEXX Laboratories Inc.
  • Thermo Fischer Scientific Inc.
  • bioMerieux SA
  • Qiagen
  • ID Vet
  • Biolab S.r.l.
  • Bionote USA Inc.
  • Zoetis, Inc.
  • Neogen Corporation

Veterinary Molecular Diagnostics Industry News:

  • In June 2022, IDEXX Laboratories, Inc expanded the reference laboratory menu by including Fecal Dx Antigen Testing with Flea Tapeworm Detection, Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service.  This strategy helped the company to enhance its existing product portfolio and increase customer base.
  • In December 2021, Neogen Corporation acquired Spokane-based Genetic Veterinary Sciences, Inc., companion animal genetic testing company. This strategic acquisition helped the company to expand its genomics business and outreach to untapped economies.

The global veterinary molecular diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product

  • Kits & Reagents
  • Instrument

By Technology

  • PCR
    • Real Time PCR
    • Other PCRs
  • DNA sequencing
  • Microarrays
  • INAAT kits

By Application

  • Infectious diseases
    • Bacterial infectious diseases
    • Viral infectious diseases
    • Parasitic infectious diseases
    • Other infectious diseases
  • Genetic diseases
  • Other applications

By Animal Type

  • Companion animals
    • Dogs
    • Cats
    • Horses
    • Other companion animals
  • Livestock animals
    • Cattle
    • Swine
    • Poultry
    • Other livestock animals

By End-user

  • Diagnostic laboratories
  • Veterinary clinics
  • Veterinary hospitals
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for veterinary molecular diagnostics was USD 298 million in 2022 and is anticipated to reach USD 678.8 million by 2032 owing to the increasing adoption of companion animals along with the high prevalence of zoonotic and foodborne diseases

The kits & reagents segment generated USD 209 million in revenue in 2022 and is expected to gain significant momentum through 2032 owing to increasing demand of infectious disease diagnostic testing in companion and livestock animals.

North America market is expected to expand at 8.1% CAGR from 2023 to 2032 owing to the presence of well-developed veterinary healthcare infrastructure in the region

Some of the top companies engaged in the veterinary molecular diagnostics market are IDEXX Laboratories Inc., Thermo Fischer Scientific Inc., bioMerieux SA, Qiagen, ID Vet, Biolab S.r.l., INDICAL BIOSCIENCE GmbH, Bionote USA Inc., Zoetis, Inc., and Neogen Corporation.

Veterinary Molecular Diagnostics Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 539
  • Countries covered: 19
  • Pages: 313
 Download Free Sample